MAPT and tauopathy: A recent study utilizing anti-sense oligonucleotides (ASOs) to decrease total APOE4 levels showed significant protection against tau pathology, neurodegeneration and neuroinflammation in a P301S/APOE4 tauopathy mouse model72.